These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 9988509

  • 21. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Weig M, Müller FM.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Current approach to the acute management of cryptococcal infections.
    Powderly WG.
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Discrepancy between in vitro and in vivo antifungal activity of albendazole.
    Hardin TC, Najvar LK, Rizzo J, Fothergill AW, Rinaldi MG, Graybill JR.
    J Med Vet Mycol; 1997 Jul; 35(3):153-8. PubMed ID: 9229330
    [Abstract] [Full Text] [Related]

  • 27. Cryptococcosis: clinical and biological aspects.
    Kwon-Chung KJ, Sorrell TC, Dromer F, Fung E, Levitz SM.
    Med Mycol; 2000 Jul; 38 Suppl 1():205-13. PubMed ID: 11204147
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Dispiropyrrolidine tethered piperidone heterocyclic hybrids with broad-spectrum antifungal activity against Candida albicans and Cryptococcus neoformans.
    Lawson S, Arumugam N, Almansour AI, Suresh Kumar R, Thangamani S.
    Bioorg Chem; 2020 Jul; 100():103865. PubMed ID: 32361055
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mycoses associated with AIDS in the Third World.
    Marques SA, Robles AM, Tortorano AM, Tuculet MA, Negroni R, Mendes RP.
    Med Mycol; 2000 Jul; 38 Suppl 1():269-79. PubMed ID: 11204155
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, Spain.
    Guinea J, Hagen F, Peláez T, Boekhout T, Tahoune H, Torres-Narbona M, Bouza E.
    Med Mycol; 2010 Nov; 48(7):942-8. PubMed ID: 20297948
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Nosocomial fungal infections, analysis of 149 cases].
    Liu ZY, Sheng RY, Li XL, Li TS, Wang AX.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):399-402. PubMed ID: 12820917
    [Abstract] [Full Text] [Related]

  • 40. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
    Pappalardo MC, Szeszs MW, Martins MA, Baceti LB, Bonfietti LX, Purisco SU, Baez AA, Melhem MS.
    Diagn Microbiol Infect Dis; 2009 Jun 10; 64(2):146-51. PubMed ID: 19345042
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.